Key facts
- This page summarizes Beth C. Seidenberg's Form 4 filing for Vera Therapeutics, Inc. (VERA).
- 2 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 30 Oct 2024, 16:06.
Beth C. Seidenberg - 28 Oct 2024 Form 4 Insider Report for Vera Therapeutics, Inc. (VERA)
- Reporting relationship
- Director
- Issuer ticker
- VERA
- Reported as of
- 28 Oct 2024
- Net transaction value
- -$720,493
- SEC form
- 4
- Accepted by SEC
- 30 Oct 2024, 16:06:24 UTC
- Prior SEC filing
- 20 Sep 2024
- Next SEC filing
- 16 May 2025
- Source filing
- View source filing
- Reporting owner signature
- /s/ Joseph R. Young, Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Beth C. Seidenberg filed Form 4 for Vera Therapeutics, Inc. (VERA) on 30 Oct 2024.
Change
- Previous filing in this sequence was filed on 20 Sep 2024.
- Current net transaction value: -$720,493.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
VERA
transaction
Class A Common Stock
Sale
- Transaction value
- $710,486
- Shares
- -14,798
- Change %
- -10%
- Price
- $48.01
- Shares after
- 131,755
- Date
- 28 Oct 2024
- Ownership
- Direct
- Footnotes
- F1, F2
VERA
transaction
Class A Common Stock
Sale
- Transaction value
- $10,007
- Shares
- -202
- Change %
- -0.15%
- Price
- $49.54
- Shares after
- 131,553
- Date
- 28 Oct 2024
- Ownership
- Direct
- Footnotes
- F1, F3
VERA
holding
Class A Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 4,012
- Date
- 28 Oct 2024
- Ownership
- See Footnote
- Footnotes
- F4
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Rule 10b5-1 trading plan
These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.
Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).
Explanation of responses 4 footnotes
Footnote F1
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 19, 2024.
Footnote F2
The price reported is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $48.00 to $48.30, inclusive. The Reporting Person will provide upon request to the staff of the Securities and Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares sold at each separate price.
Footnote F3
The price reported is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $49.50 to $49.70, inclusive. The Reporting Person will provide upon request to the staff of the Securities and Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares sold at each separate price.
Footnote F4
Shares are held by the Samuel B. Seidenberg Irrevocable Trust, established on July 1, 2013, for which the Reporting Person and her spouse serve as trustees.